Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
specificStage IV includes: IVA: (T4, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)
23
Centers
25
Active Trials
—
Cancer Funding
Top Centers for Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8(23)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 71.7 |
| 2 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 71.7 |
| 3 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL High-Volume Research Center | 71.7 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.2 |
| 5 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 50.2 |
| 6 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 50.2 |
| 7 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 50.2 |
| 8 | NCI Comprehensive Active Research Program | 50.2 |
| 9 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 50.2 |
| 10 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 50.2 |
| 11 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 50.2 |
| 12 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 50.2 |
| 13 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 50.2 |
| 14 | NCI Clinical Active Research Program | 50.2 |
| 15 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 50.2 |
| 16 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.2 |
| 17 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 50.2 |
| 18 | Boston University Cancer CenterBoston, MA Active Research Program | 50.2 |
| 19 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 50.2 |
| 20 | Cancer Center at IllinoisUrbana, IL Active Research Program | 50.2 |
| 21 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 50.2 |
| 22 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 50.2 |
| 23 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 30.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →